|
|
|
05 Dec 2006 |
Genmab Announces Positive Interim Data For The Humax-Cd20 Phase II RA Study
|
|
05 Dec 2006 |
Study Showed Epratuzumab in Combination with Rituximab and Chemotherapy is Safe, Tolerable, and Active in Aggressive Lymphoma
|
|
30 Nov 2006 |
Anti-Cancer Agent, Herceptin® Application for Approval of Additional Indication of Operable Breast Cancer with HER2 Overexpression
|
|
29 Nov 2006 |
Biolex Announces Publication in Nature Biotechnology Demonstrating Potential To Produce Monoclonal Antibodies with Increased Potency and Efficacy
|
|
28 Nov 2006 |
Protherics' DigiFab(TM) to replace Digitalis Antidot(R) in Europe
|
|
25 Nov 2006 |
Biotie And Roche Sign Agreement For VAP-1 Antibody Program
|
|
22 Nov 2006 |
European Commission grants Orphan Drug Designation for the removab(R) antibody to treat gastric cancer
|
|
22 Nov 2006 |
PDL BioPharma Announces Roche to Discontinue Co-Development of Daclizumab
|
|
18 Nov 2006 |
FibroGen Reports Results of a Phase 1b Study of FG-3019, Therapeutic Antibody Against CTGF, in Diabetic Patients with Microalbuminuria
|
|
18 Nov 2006 |
Seattle Genetics Initiates Phase I Clinical Trial of SGN-35
|
|
18 Nov 2006 |
Lucentis® receives positive European Union regulatory agency opinion for approval as new treatment for a leading cause of severe vision loss
|
|
18 Nov 2006 |
Peregrine Initiates Patient Treatment in Bavituximab Combination Therapy Cancer Trial
|
|
17 Nov 2006 |
FDA Approves Herceptin for the Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer
|
|
17 Nov 2006 |
Research Shows Potential Novel Therapeutic Antibody Effective Against Fibrotic Heart Disease
|
|
15 Nov 2006 |
FDA Grants Priority Review for Soliris(TM) (eculizumab) BLA for Treatment of Paroxysmal Nocturnal Hemoglobinuria
|
|
15 Nov 2006 |
Abbott's HUMIRA® (adalimumab) Receives FDA Approval for Inhibiting Structural Joint Damage and Improving Physical Function in Patients with Psoriatic Arthritis
|
|
15 Nov 2006 |
Human Genome Sciences Announces Positive 76-Week Results of Phase 2 Clinical Trial of LymphoStat-B(TM) in Systemic Lupus Erythematosus
|
|
14 Nov 2006 |
ZymoGenetics and Serono Report Detailed Positive Results From Atacicept Phase 1b Clinical Trial in Patients With Lupus
|
|
14 Nov 2006 |
Anti-TNF Golimumab (CNTOnto 148) Continues To Show Promise In Phase 2 Rheumatoid Arthritis Study
|
|
14 Nov 2006 |
New Study Shows ACTEMRA(TM) (tocilizumab) Significantly Improves Remission Rates in Patients with Rheumatoid Arthritis
|
|
13 Nov 2006 |
ENBREL is the First Biologic to Publish Data Showing Safety and Sustained Efficacy for up to Nine Years in Patients with Moderate-to-Severe Rheumatoid Arthritis
|
|
12 Nov 2006 |
Subsequent Course of Rituxan Improved Outcomes in Rheumatoid Arthritis Patients Who Inadequately Responded to TNF Antagonist Therapy
|
|
11 Nov 2006 |
ImmunoGen, Inc. Announces Presentation of HuN901-DM1 Clinical Data At EORTC-NCI-AACR Conference Showing Compound is Well Tolerated and Demonstrates Anticancer Activity
|
|
10 Nov 2006 |
KaloBios Commences Clinical Trial of Novel Antibody Rheumatoid Arthritis Drug Candidate
|
|
10 Nov 2006 |
Two-Year Data for ORENCIA(R) (abatacept) Demonstrate Continued Efficacy in Adults With Rheumatoid Arthritis
|
|
09 Nov 2006 |
ImmunoGen, Inc. Announces Presentation of HuC242-DM4 Clinical Data at EORTC-NCI-AACR Conference
|
|
09 Nov 2006 |
Roche Presents Positive Preclinical Data On Genmab Antibody
|
|
09 Nov 2006 |
Human Genome Sciences Reports Interim Results Of Phase 1b Clinical Trial Of Hgs-Etr1 With Gemcitabine And Cisplatin In Patients With Advanced Solid Tumors
|
|
08 Nov 2006 |
Medarex and PacMab Announce Therapeutic Antibody Co-Development Agreement
|
|
08 Nov 2006 |
Monoclonal Antibody, MORAb-009, Receives FDA Orphan Drug Designation for the Indication of Pancreatic Cancer
|
|
08 Nov 2006 |
Infinity and MedImmune Announce Promising Biological Activity of Anti-Hsp90 Compound in Phase I GIST Trial
|
|
07 Nov 2006 |
Survival Data Available From Two Randomized Erbitux Studies In Metastatic Colorectal Cancer
|
|
07 Nov 2006 |
Numax Achieves Primary Endpoint In Preliminary Analysis of Data From Comparative Phase 3 Trial With Synagis
|
|
03 Nov 2006 |
XOMA and Takeda Establish Collaboration for Therapeutic Antibody Discovery and Development
|
|
03 Nov 2006 |
AstraZeneca Updates CytoFab(TM) Development Programme
|
|
03 Nov 2006 |
Bradmer granted orphan drug designation for Neuradiab in the treatment of glioblastoma multiforme by European Medicines Agency
|
|
01 Nov 2006 |
Dyax and ZymoGenetics Enter Into Library License Agreement for Discovery of Therapeutic Antibodies
|
|
31 Oct 2006 |
24-Week Clear Study Results Confirm Sustained Efficacy And Safety Of Raptiva® In Moderate-To-Severe Psoriasis Patients With Co-Morbidities
|
|
31 Oct 2006 |
BioWa, Inc. Begins Phase 1 Clinical Trial in Asthma
|
|
31 Oct 2006 |
Positive Results From Peregrine's Bavituximab Phase Ia HCV Trial Presented At AASLD Meeting
|
|
27 Oct 2006 |
Human Genome Sciences Announces Positive Special Protocol Assessment From Fda For Phase 3 Clinical Trials Of Lymphostat-B™ In Systemic Lupus Erythematosus
|
|
27 Oct 2006 |
LAB International Announces Letter Of Intent To Acquire Pharmaform L.L.C.
|
|
26 Oct 2006 |
Tanox Initiates Phase 1 Clinical Trial Evaluating TNX-650 for Treatment of Asthma
|
|
26 Oct 2006 |
Micromet Presents New Anti-IL-2 Antibody with Unique Mode of Action
|
|
25 Oct 2006 |
Peregrine Completes Patient Enrollment in Phase Ib Bavituximab Hepatitis C Trial
|
|
25 Oct 2006 |
Genmab Initiates Combination Study Of HUMAX-EGFR With Chemo-Radiation
|
|
25 Oct 2006 |
Abbott's Humira® (Adalimumab) Granted FDA Priority Review for the Treatment of Moderately to Severely Active Crohn's Disease
|
|
24 Oct 2006 |
New Analysis Shows CIMZIA™ (Certolizumab Pegol) Maintained Remission and Response in Recent Onset Crohn’s Disease
|
|
24 Oct 2006 |
New Efficacy Data Show CIMZIA™ (Certolizumab Pegol) Maintained Response and Remission in Crohn’s Patients Previously Treated With Infliximab
|
|
24 Oct 2006 |
New Phase III Data Shows Abbott's HUMIRA(R) (adalimumab) Induced Clinical Remissions in Patients with Crohn's Disease Who Lost Response To, or Were Intolerant To, Remicade(R) (infliximab)
|
| |
|
Results 801 - 850 of 1155 |
